Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;49(11):1441-1442.
doi: 10.1016/j.ajic.2021.08.010. Epub 2021 Aug 18.

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Ashish Bhargava  1 , Kathleen Riederer  2 , Mamta Sharma  2 , Elisa Akagi Fukushima  2 , Leonard Johnson  2 , Louis Saravolatz  2
Affiliations

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Ashish Bhargava et al. Am J Infect Control. 2021 Nov.

Abstract

We investigated the clinical implications of bacteremia among hospitalized COVID-19 patients. Higher rates (52.1%) of multidrug resistant organisms (MDRO) were noted on hospital admission compared to nosocomial acquisition (25%). Methicillin resistant Staphylococcus aureus was the predominant pathogen. Bacteremia with MDRO should be considered in the differential diagnosis among at risk populations especially those admitted from nursing facilities.

Keywords: Antimicrobial resistance; Bacteremia; Bloodstream infections; SARS-CoV-2.

PubMed Disclaimer

References

    1. Vaughn VM, Gandhi T, Petty LA. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital Cohort Study. Clin Infect Dis. 2021;72:e533–e541. PMID:32820807; PMCID: PMC7499526. - PMC - PubMed
    1. Rothe K, Feihl S, Schneider J. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021;40:859–869. PMID:33140176; PMCID: PMC7605734. - PMC - PubMed
    1. Sepulveda J, Westblade LF, Whittier S. Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol. 2020;58 PMID:32404482; PMCID: PMC7383550. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Multidrug-resistant organisms (MDRO) management. Available at: https://www.cdc.gov/infectioncontrol/guidelines/mdro/ Accessed March 17, 2021.
    1. Akagi E, Sharma M, Johnson LB. Clinical features and risk factors for community onset bloodstream infections among COVID-19 patients. Infect Control Hosp Epidemiol. 2021;42:899–901. PMID:33706821. - PMC - PubMed